Silver Book

Silver Book Fact

Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.

Goel S, Bajaj N, Agaarwall B, Gupta S, et al. Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure. J Am Coll Cardiol. 2014; 63(2). http://www.onlinejacc.org/content/63/2/185

Reference

Title
Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Goel S, Bajaj N, Agaarwall B, Gupta S, et al.
Volume & Issue
Volume 63, Issue 2
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Mitral Valve Disease

Fact image
Human Burden

Mitral Valve Disease

Fact image
Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
Human Burden

Aortic Stenosis

Fact image
Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
Human Burden

Related Facts

  • On average, myocardial infarction causes an estimated 15 years of lost life.  
  • Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.
     
  • Venous thromboembolism hospitalization rates
    An estimated 250,000 patients are hospitalized each year with venous thromboembolism.  
  • Stroke accounts for 1 in every 18 deaths in the U.S.  
  • Five-year health care resource use in medically managed SAS patients